HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kentaro Yoshii Selected Research

Vaccines

8/2019Trans Complementation of Replication-defective Omsk Hemorrhagic Fever Virus for Antiviral Study.
1/2016Novel antiviral activity of bromocriptine against dengue virus replication.
2/2014Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
12/2011Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice.
11/2008Genetic and antigenic analyses of a Puumala virus isolate as a potential vaccine strain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kentaro Yoshii Research Topics

Disease

24Infections
12/2023 - 06/2006
5Tick-Borne Encephalitis (Encephalitis, Tick Borne)
01/2020 - 06/2006
4West Nile Fever
01/2021 - 12/2011
3Encephalitis (Encephalitis, Rasmussen)
12/2023 - 06/2006
3Virus Diseases (Viral Diseases)
01/2023 - 03/2011
3Hemorrhagic Fever with Renal Syndrome (HFRS)
04/2011 - 11/2008
2Flavivirus Infections
08/2019 - 01/2019
1Meningitis
12/2023
1Nervous System Diseases (Neurological Disorders)
10/2020
1Severe Fever with Thrombocytopenia Syndrome
01/2018
1Hepatitis A (Hepatitis, Infectious)
06/2017
1Neuroblastoma
03/2016
1Communicable Diseases (Infectious Diseases)
01/2016
1Primary Immunodeficiency Diseases
07/2015
1Hantavirus Infections
09/2012
1Thrombosis (Thrombus)
09/2011
1Persistent Infection
01/2007

Drug/Important Bio-Agent (IBA)

7AntibodiesIBA
12/2023 - 01/2007
7Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2008
5Neutralizing AntibodiesIBA
10/2020 - 01/2009
5VaccinesIBA
08/2019 - 11/2008
4Immunoglobulin M (IgM)IBA
12/2023 - 06/2006
4EnzymesIBA
11/2018 - 06/2006
4ImmunosorbentsIBA
11/2018 - 06/2006
4AntigensIBA
03/2016 - 01/2007
3Immunoglobulin G (IgG)IBA
12/2023 - 06/2006
3Nucleocapsid ProteinsIBA
01/2022 - 09/2012
3Viral RNAIBA
04/2014 - 01/2007
2Antiviral Agents (Antivirals)IBA
08/2019 - 01/2016
2RNA (Ribonucleic Acid)IBA
08/2019 - 01/2007
1UbiquitinIBA
11/2023
1Phosphotransferases (Kinase)IBA
11/2022
1Glutathione Transferase (Glutathione S-Transferase)IBA
02/2021
1Amino AcidsFDA Link
01/2020
1Viral Structural Proteins (VP(1))IBA
01/2018
1NucleosidesIBA
11/2017
1ApolipoproteinsIBA
06/2017
1longicinIBA
02/2016
1proline dipeptidase (prolidase)IBA
07/2015
1dipeptidaseIBA
07/2015
13' Untranslated Regions (3' UTR)IBA
04/2014
1Viral AntigensIBA
04/2014
1Indicators and Reagents (Reagents)IBA
09/2012
1NucleotidesIBA
04/2011
1LuciferasesIBA
10/2009
1feralIBA
08/2009
1Subgenomic RNAIBA
01/2008

Therapy/Procedure

1Therapeutics
11/2017